Skip to content

Blunt Commends President Trump’s Decision to Keep Dr. Francis Collins as NIH Director

June 06, 2017

WASHINGTON – U.S. Senator Roy Blunt (Mo.), Chairman of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, released the following statement on President Trump’s announcement that Dr. Francis Collins will continue serving as Director of the National Institutes of Health.

“I’m pleased that President Trump has asked Dr. Collins to continue leading the world’s premier biomedical research agency,” Blunt said. “As chairman of the Senate appropriations subcommittee that funds NIH, I’ve been proud to lead efforts to increase federal resources for the agency, while eliminating dozens of ineffective or duplicative programs elsewhere in the government.”

As chairman of the Labor/HHS subcommittee, Blunt has secured a total increase of $4 billion for NIH over the past two years, a 13.3 percent increase. That is a larger increase in two years than NIH received in the past 10 years combined.

Blunt continued, “Dr. Collins has been, and will continue to be, a strong partner in making the case for a sustained federal commitment to medical research. I look forward to working with him to ensure NIH has the resources it needs to advance progress toward new, life-saving treatments and cures.”

Dr. Francis Collins has served as NIH Director since 2009. Prior to that, he was the Director of the National Human Genome Research Institute, where his groundbreaking work on the Human Genome Project earned him the Presidential Medal of Freedom and the National Medal of Science.



Next Article » « Previous Article